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Abstract Theories on the importance of cytokinins in G1/S
transition control are manifold and contradictory. By establish-
ing a double AB-PZ block, maximal synchronization of a BY-2
suspension culture was obtained to investigate the effect of
cytokinin depletion on G1/S transition. Lovastatin was used as a
specific inhibitor of cytokinin biosynthesis. Flow cytometry
showed that the G1/S transition occurred regardless of the
cytokinin drop. This observation indicates an extremely low dose
requiry for that stage of the cell cycle. It is very likely that
precisely the downregulation of zeatin type cytokinins matters
for the G1/S transition to occur, since cytokinin addition at early
G1 blocked the cycle at G1/S.
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1. Introduction
Discovering the role of cytokinins in cell division control is
of vital importance for both fundamental and applied biology.
Skoog et al. [1] concluded that cytokinins are required at three
stages of the cycle: G1/S, G2/M and Cy (cytoplasmic division).
More recent work also indicates that S, G2 and M are possi-
ble points of control [2^4].
Because of their pleiotropic e¡ects, it is likely that if cyto-
kinins are indeed indispensable at these di¡erent stages, their
mode of action might be totally di¡erent for each situation.
Several studies demonstrated that withdrawal of cytokinins in
cell suspension cultures results in the arrest of cell cycle and
the partially synchronous recovery upon exogenous addition
of cytokinins [5^8]. On the other hand, application of cytoki-
nins to whole plants often does not promote but rather inhib-
its growth [9]. This might be due to the fact that plants nor-
mally contain optimally balanced cytokinin levels and extra
supply is unnecessary or even detrimental.
Although older results seem to indicate that cytokinin ad-
dition does not in£uence total protein synthesis [10^12], ex-
periments on Sinapis showed that addition of cytokinins at
the start of the S-phase activated all replication origins syn-
chronously [13,14]. Moreover, BA succeeded in shortening S-
phase markedly. Cytokinins are thus supposed to increase the
availability of one key protein component common to all
replication complexes. In this perspective, the induction of
CycD3 by cytokinins just before S-phase entry has been illus-
trated in Arabidopsis [15]. This induction, which probably in-
volves regulatory phosphorylations according to Riou-Kham-
lichi et al., is independent of progression through G1 and
involves signal transduction by proteins already present in
stationary phase cells.
Since both G1/S and G2/M transitions are likely controlled
by a series of coupled protein phosphorylations initiated by
cyclin dependent kinases (CDKs), one may speculate that cy-
tokinins exert their control via these proteins in some way.
The fact that addition of BA increased RNA levels of G1, S
and G2 nuclei and particularly in£uenced mRNA for CDKs
[16,17] supports that assumption. According to Zhang et al.
[18], it is during late G2 exclusively that cytokinins act as
activators of the p34cdc2-like histone kinase through the de-
phosphorylation of the enzyme.
The rapid and cytokinin-autonomous cell cycle of
synchronized tobacco BY-2 cell suspension cultures [19]
makes them ideal tools to study cytokinin control mechanisms
on cell cycle progression. This cytokinin-autonomous charac-
ter of BY-2 cells is linked to their capacity to synthesize the
necessary cytokinin amounts at the precise moment cell cycle
events require them [20,21].
Our previous work showed that it is at G2/M in particular
that zeatin is indispensable for the normal course of cell divi-
sion [22]. This conclusion was linked to the observation that
in suspension cultures of BY-2 cells, two transient high peaks
in endogenous zeatin type cytokinins occur: around G1/S and
at G2/M [23,24].
The control of G1/S by cytokinins is undoubtedly an im-
portant issue, since related theories are manifold. First, there
is the observation that soybean cells in suspension deprived of
cytokinins were apparently able to undergo several rounds of
DNA replication without cell division [3]. Endomitosis is a
clear indication that one single step of the cycle requires cy-
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tokinins stringently and that this step occurs after S-phase,
possibly at G2/M. This interpretation has been challenged
by more recent ¢ndings showing that several stages of the
cell cycle require cytokinins [6,10]. Until now, such discrep-
ancies remain unsolved, but it might be a matter of di¡erences
in origin, culture conditions or synchronization methods of
the cells.
Keeping this in mind, we chose to perform a double block
with AB and PZ [25,26] to obtain maximum synchronization
rates in BY-2 suspension cultures. Because lovastatin speci¢-
cally inhibits MA biosynthesis, we used it to a¡ect formation
of endogenous cytokinins downstream in the pathway [28^31].
In this fashion, the in£uence of zeatin type cytokinin content
on G1/S transition could be investigated. Flow cytometry al-
lowed us to monitor the occurrence of G1/S in the cells with
or without inhibition of cytokinin biosynthesis.
2. Materials and methods
2.1. Chemicals
AB batches from ICN (Asse, Belgium) were used for synchroniza-
tion purposes. All cytokinin-deuterated tracers ([2H5]Z, [2H5]ZR,
[2H5]Z9G, [2H5]ZOG, [2H5]ZROG, [2H6]iP, [2H6]iPA, [2H6]iP9G,
[2H3]DZ, [2H3]DZR) were purchased at Apex (Honiton, UK). Lova-
statin lactone was kindly provided by Merck (Rahway, NJ, USA).
The lactone rings of lovastatin were hydrolyzed before application
as described by Crowell and Salaz [28]. PI, like all other chemicals
used for nuclei isolation, was bought at Sigma (Bornem, Belgium). PZ
was provided by Chemservice (West Chester, PA, USA).
2.2. Culture maintenance and synchronization
BY-2 cultures were maintained in a Murashige and Skoog-based
medium (Duchefa, Haarlem, The Netherlands), according to the
method of Nagata et al. [19]. To obtain a maximum synchronization
rate, a sequential AB-PZ block was performed.
In a ¢rst step, AB was added to an end concentration of 5 Wg/ml in
fresh medium, to which 1:10 (v/v) of stationary culture was added.
After 24 h, the drug was removed by extensive washing and the
shifted cells were released in fresh medium containing 1.54 Wg/ml of
PZ for the second step of synchronization [25,26]. Once an MI of
minimum 85% was reached (6 to 7 h after release from AB), the cells
were immediately washed and released in fresh medium supplemented
with vitamins and 2,4-D [19].
2.3. Determination of the MI
Four to 8 h after release from AB, aliquots of cells were ¢xed with
ethanol/acetic acid (3:1, v/v) and stained with 1 Wg/ml DAPI for
immediate evaluation of the MI. A £uorescence microscope (Leitz,
Germany) was used to count the number of nuclei arrested in prom-
etaphase due to the presence of PZ. An average MI value of 92%
( þ 4.5%) was reached during the six independent double synchroniza-
tions carried out in this paper. Synchronization rates within the 90%
range (obtained after a sequential AB-PZ block) have already been
experienced in several other cases [25,26]. The addition time of the
second blocking agent (PZ) is crucial for the attainment of very high
synchronization rates. The method proposed by Samuels et al. [27]
proposes PZ addition 3 h after release from AB. This 3 h lag-phase
might account for a loss in sychronization percentage already estab-
lished with AB, since MI under these conditions did never exceed 81%
[27].
The MI was counted a second time between 17 and 20 h after
release from AB.
2.4. Sampling of the cells
After completion of the M-phase (8 h after release from AB), the
culture was split up in a control batch and a batch treated with 10 WM
lovastatin. From that moment onward, samples were taken every
hour either for nuclei isolation or for LC-MS/MS analysis. While
the latter were frozen in liquid nitrogen and stored at 370‡C until
extraction, the ¢rst samples were immediately processed for nuclei
puri¢cation.
2.5. Nuclei isolation and £ow cytometry
Nuclei were isolated in a stepwise protocol of enzymatic and os-
motic treatments and stored at 4‡C in the presence of 0.8% form-
aldehyde. Several currently used protocols were compared as to cen-
trifugation speed and amount of osmotic steps [25,26,32^34]. The
scope of this comparison was to obtain a method in which ‘gentleness’
could be combined to maximum yield, since it is known that centri-
fugation speed and the choice of ¢xative can cause clumping [34]. An
independent study was carried out as to the incubation time, temper-
ature, batch strength and concentration of the enzymatic solutions. By
means of an inverted microscope (Nikon Diaphot TMD), the optimal
digestion method was selected based on a judgement of when the
greatest proportion of released protoplasts had assumed a spherical
shape. Finally, an enzyme ratio of 0.1% pectolyase versus 2% cellulase
(8.4 units/mg) was chosen for further experiments. The addition of a
non-ionic detergent (1% Triton X-100) to the hypotonic bu¡er solu-
tion (Galbraith), allowed non-speci¢cally stained cytoplasmic frag-
ments to be removed [34]. The standard method developed by Ber-
gounioux et al. [32] was thus only slightly modi¢ed, mostly in respect
of centrifugation speed. The basic lysis method was followed and
sorbitol was preferred to mannitol as an osmotic agent, both on
account of its higher solubility and of the absence of crystals being
formed which could hinder cytometry (Brown, S.C., personal commu-
nication).
Because aldehyde ¢xation can increase the refractive index of the
cytoplasm, which could a¡ect the precision of the £uorescence meas-
urement [34], the nuclei were rinsed in PBS twice and centrifuged at
low speed (1000 rpm) before applying the three-step Vindelov staining
method. A comparison was made with a simple dye containing only
PI (50 Wg/ml) and RNAse (5 Wg/ml), but the Vindelov method pro-
duced clearer histograms [35]. If combined with an RNAse, PI is still
a very e⁄cient DNA-speci¢c staining agent with a broad excitation
band in UV. Low speed centrifugation had the disadvantage of pro-
ducing a less coherent pellet ^ which caused loss of nuclei during the
staining procedure (treatment with trypsine and RNase A and stain-
ing with 10 Wg/ml PI) ^ but, on the other hand, kept the nuclei intact.
A FACS-scan £ow cytometer was used for analysis.
2.6. Extraction, puri¢cation and quantitative electrospray LC-MS/MS
analysis of cytokinins
Frozen cells were pulverized in liquid nitrogen and extracted over-
night at 320‡C in Bieleski solvent (CHCl3, CH2OH, H2O, HCOOH,
5:12:2:1, v/v) [36]. Approximately 20 pmol of each deuterated cyto-
kinin was added as an internal standard. Solid-phase extraction and
immune a⁄nity puri¢cation were conducted according to the existing
protocols [37]. The samples obtained that way were stored at 370‡C
until analysis by (+ES)LC-MS/MS. The cytokinins could be analyzed
and quanti¢ed by means of their diagnostic transitions under a multi-
ple reaction monitoring mode [38]. The internal standard ratio meth-
od allowed the computation of endogenous cytokinin concentrations.
Fig. 1. E¡ect of lovastatin on the second round of mitosis after G1/
S transition. MI in control conditions (a) and in presence of 10 WM
L (F).
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3. Results
3.1. E¡ect of lovastatin (with or without cytokinins) on the
G1/S transition
Addition of lovastatin allowed a closer look at the G1/S
transition in presence or absence of cytokinins. Sharper £ow
cytometry results could be obtained when maximum synchro-
nization rates were induced by a double AB-PZ block. At 6 h
after release from AB, the majority of cells was blocked in
prometaphase due to the presence of PZ (Fig. 1). The second
rinse allowed them to leave M-phase about 2 h later. The
double blocking method easily produced synchronization
rates within the 90% range [25,26] (Fig. 1). However, one
must take into account that synchronization decreases rather
quickly and can only be maintained for about one cycle round
[19]. The synchrony at 10 h (¢rst histogram shown) will there-
fore already have dropped in respect to the initial high to very
high values at 7 h and this is exactly the reason why we aimed
Fig. 2. E¡ect of the addition of L (10 WM) and L+Z (8 WM) to a cell population accumulated into the M-phase after double AB-PZ block.
Flow cytometry analyses.
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for maximum synchronization rates by double block. After
taking one sample in control conditions at 8 h, the culture
was split up and lovastatin (10 WM) was added in one batch.
In another batch, lovastatin (10 WM) and zeatin (8 WM) were
added. The cells were in M/G1 at the time of addition (Fig. 1).
From that point, samples were taken every hour until G2 set
in. Cell cycle progression was analyzed by £ow cytometry
(Fig. 2). The experiment was repeated six times. The results
were fully reproducible.
For the sake of uniformity, all time points are given as ‘time
after release from AB’ even though in every experiment a PZ
block was also performed and released 6^7 h later. Fig. 1
shows the X-axis as it will be considered in the entire exper-
imental description and gives a clear view of the entire setup.
The period between ¢rst and second mitosis is visualized by
the histograms in Fig. 2.
At 10 h after release from AB (or 3 h after release from PZ),
the cells were into G1-phase (Fig. 2). A large amount of S-
phase appeared consistently at about 13 h, in control condi-
tions as well as in the presence of lovastatin. At 16 h, cells
underwent G2 regardless of the fact that lovastatin was
present or not. Considering the loss of synchrony after one
cell cycle [19], the apparent broader peakshape in the 16 h
histogram is an expected phenomenon.
In the presence of 8 WM zeatin however, the cell cycle could
only evolve very slowly towards S-phase. It was not before 14
h after release from AB that a minor decrease in the amount
of G1 cells was observed. Within the 16 h of observation, the
S-plateau did not occur. This particular experiment was re-
peated two times with comparable e¡ects.
The same experiment was repeated with 8 WM concentra-
tions of ZR and iP in the presence of lovastatin, with similar
inhibiting e¡ects on the G1/S transition (data not shown).
3.2. E¡ect of lovastatin on the second round of mitosis
In order to ensure ourselves of the stability of lovastatin in
the culture medium, a double block was conducted in the way
described above. MI at the ¢rst mitotic peak reached an aver-
age of 92% (Fig. 1). The culture was also split in two batches
at 8 h after release from AB : control and lovastatin (10 WM).
The cultures were allowed to grow for 8 h after treatment with
lovastatin.
Then, samples were taken for the determination of the MI
at the second putative mitosis. This experiment was repeated
twice with comparable results. The second mitotic peak in-
deed occurred between 18 and 19 h after release from AB.
An average residual MI of 25% was obtained in control con-
ditions, whereas MI only reached an average of 12% in the
presence of lovastatin.
3.3. E¡ect of lovastatin on the endogenous cytokinin content
Table 1 unequivocally shows that application of lovastatin
induces a severe drop in any endogenous cytokinin level. In
control conditions, the expected peaks are observed before
occurrence of G1/S [23]. More precisely, peaks in the zeatin
content are observed at 9 h (cells entering G1) and around 13
h (G1+early S) (Fig. 2). For ZR and ZRP, one dominating
peak is reached at 11 h (G1+early S). Lovastatin almost to-
tally succeeded in blocking the formation of all zeatin type
cytokinins by the time G1/S was expected (12 h).
4. Discussion
The requirement for high transient zeatin type cytokinin
levels at the G1/S transition of tobacco BY-2 cells was inves-
tigated by means of a sequential AB-PZ block followed by
£ow cytometry on control and lovastatin-treated samples.
BY-2 cells exhibit stringently regulated kinetics of their endog-
enous cytokinin levels [20^22]. As stated previously, transient
high peaks in zeatin type cytokinins are noticed not only at
G2/M, but also around G1/S [23,24]. Our former research
proved zeatin to be essential for G2/M transition in the BY-
2 system [22]. It was the main issue of this paper to check
whether the same assumption could be made for the G1/S
transition.
Our data show that addition of lovastatin at M/G1 did
indeed block the cytokinin biosynthesis severely (Table 1),
but did not a¡ect the normal transition from G1 to S (Fig.
2). Surprisingly, addition of 8 WM zeatin in the presence of
lovastatin, prevented normal progression through S-phase
(Fig. 2).
To ensure ourselves of the stability of lovastatin after sev-
eral hours in culture medium, the occurrence of a second cycle
was investigated. Therefore, the second MI count started 8 h
after addition of lovastatin (Fig. 1). Cells can only maintain
high synchronicity for about one cycle and the MI values of
this second count would never have reached a signi¢cant per-
Table 1
Endogenous cytokinin levels (pmol/gfw) during the G1/S transition
of a synchronized BY-2 cell culture (C) and e¡ect of 10 WM lovasta-
tin (L) on endogenous cytokinin (CK) concentrations
CK Time after release
from AB (h)
Conditions
C L
Z 9 344 ^
10 274 18
11 205 9
12 90 11
13 179 28
DZ 9 29 ^
10 75 16
11 0 0
12 94 0
13 0 0
ZR 9 193 ^
10 249 179
11 673 15
12 5 7
13 54 4
DZR 9 7 ^
10 9 5
11 20 1
12 1 1
13 2 1
ZNG 9 2 ^
10 9 11
11 5 3
12 9 10
13 5 6
ZRP 9 93 ^
10 117 165
11 535 23
12 34 18
13 45 3
DZRP 9 4 ^
10 5 5
11 18 1
12 1 1
13 2 0
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centage without inducing a maximum synchronization rate at
the start of the experiment. This is why the double AB-PZ
blocking method was chosen. To prove that lovastatin re-
mained e¡ective throughout the entire experiment, a drop in
MI had to be observed during the second M-phase, which was
the case. This ratio of a 50% decrease in MI in the presence of
lovastatin is a phenomenon also observed when lovastatin is
added before the ¢rst G2/M transition [22,31], showing that
the compound is still e⁄cient after remaining in culture me-
dium for one complete cell cycle. Not only does this observa-
tion validate the £ow cytometry data obtained; it additionally
proves that lovastatin was active in the culture medium during
the entire transition from G1 to second G2/M over S and that
any stringent dose dependent e¡ect of cytokinins during that
part of the cycle can be ruled out.
Obviously, high cytokinin levels at G1/S are not necessary
for the cells to continue their cycle. This does not mean,
however, that they are of no use at that time and place. A
¢rst possible explanation could be that the cells simply do not
need such high endogenous concentrations to proceed with
their division cycle at that point. This theory can be supported
by the observation that extra addition of zeatin, which ^ after
all ^ shows a prominent endogenous peak at M/G1, prevents
the occurrence of S-phase in the presence of lovastatin (Fig.
2). Moreover, the same phenomenon could be observed when
ZR and iP were added. This suggests that if any cytokinin
level is necessary for G1/S transition, it is amply su⁄cient even
after lovastatin has downregulated most of its biosynthesis. A
reasonable train of thought, since literature proved over the
past several years that overexposure to cytokinins can easily
block the cell cycle [9]. Keeping in mind that the BY-2 cell is
cytokinin autotroph and can thus perfectly regulate its own
biosynthetic supplies according to the needs of the moment,
these observations certainly make sense. One might even sus-
pect that it is exactly this overexposure that is to be avoided
to reach the S-phase. It could thus well be the explicit down-
regulation of zeatin type cytokinins at G1 rather than the peak
at M/G1 that triggers the G1/S transition. Additionally, the
results of Hemmerlin and Bach [31] prove that G1/S transition
was only blocked by lovastatin after a 36 h treatment with the
drug. After that period of time, the naturally occurring cyto-
kinin levels were probably totally depleted, causing the cells to
drop below their necessary minimal dose of cytokinins partic-
ipating in the downregulation signal for G1/S transition.
The e¡ect of zeatin type cytokinins at G1/S might thus be
far less direct than the type of interaction observed at G2/M
[22] and even more sensitive, judging by the very low amount
of cytokinins this transition requires. Whereas G2/M transi-
tion could be attributed to a physical interaction in the pe-
riphery of speci¢c kinases, one might think of a more basic
mechanism at G1/S, e.g. the regulation of transcription by an
on-o¡ switch mechanism. This idea can be supported by the
observations of Riou-Khamlichi et al. [15] on CycD3 activa-
tion by an external cytokinin signal at that stage of the cell
cycle.
The nature of di¡erent kinases and cyclins was extensively
probed over the past few years and it is now accepted that
very di¡erent structures act at these two distinct stages of the
cell cycle ([2,16] are only two of the many references on the
subject). It is therefore not surprising that processes at G1/S
or G2/M di¡er in the same proportion as the active structures
themselves.
Our study indeed does not prove why a peak in zeatin type
cytokinins is observed at M/G1. But it does prove the subtle
and versatile nature of cytokinins in the plant cell. While we
can be absolutely certain about the stringent necessity of a
highly regulated zeatin peak for G2/M, it is tempting to as-
sume that it is the drop in zeatin type cytokinins that is es-
sential for G1/S to occur. The observed M/G1 peak might
therefore trigger other activities than the one just ruled out,
e.g. feedback regulation of the MA pathway. A cytokinin
peak in M/G1 might also act as a signal that the indispensable
hormone for the oncoming G2/M is being properly synthe-
sized so that it will be present at su⁄cient rates later on,
when it is needed. With all these prerequisites ful¢lled, the
cell may then safely begin a new cycle round. For the G1/S
transition itself, the nature of the process will very likely be of
another nature than a physical one, as opposite to the one
observed at G2/M. Then again, the peak around M/G1 could
be related to physical events on a protein basis, more similar
to the events in G2/M. Recent ¢ndings thereon showed that
the e¡ect of cytokinins might be related to the phosphoryla-
tion dephosphorylation processes activating the cyclin-kinase
complexes [18]. Since also in the beginning of G1, this type of
complexes are being formed, there might be a similar function
for cytokinins to be ¢lled in yetT.
So although this study does not explain or prove why the
content of zeatin type cytokinins undergoes a transient high
peak at M/G1, it does prove that an extremely low dose of
these compounds is required at the G1/S transition. Addition-
ally, it strongly emphasizes the exclusive nature of zeatin as a
physical G2/M trigger in the BY-2 system [22].
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